96 related articles for article (PubMed ID: 4079424)
1. Hepatic staging in operable breast cancer: a reappraisal from a prospective study.
Colizza S; Lupattelli R; De Fazio S; Preziosi P; Karakaci F; Cucchiara G
J Surg Oncol; 1985 Oct; 30(2):113-5. PubMed ID: 4079424
[TBL] [Abstract][Full Text] [Related]
2. Combined ultrasounds and CEA in preoperative assessment of hepatic metastases from gastrointestinal malignancies.
Colizza S; Lupattelli R; De Fazio S; Preziosi P; Karakachi F; Cucchiara G
J Surg Oncol; 1985 Mar; 28(3):161-4. PubMed ID: 3883060
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer.
Cetin B; Atalay C; Aslan S; Babacan B; Hatipoğlu C; Akinci M; Cetin A
Surg Today; 2005; 35(11):919-24. PubMed ID: 16249844
[TBL] [Abstract][Full Text] [Related]
4. Unresectable hepatic metastases from carcinoma of the colon and rectum.
Didolkar MS; Elias EG; Whitley NO; Keramati B; Jackson AJ; Hebel RJ; Jordan TE
Surg Gynecol Obstet; 1985 May; 160(5):429-36. PubMed ID: 3992446
[TBL] [Abstract][Full Text] [Related]
5. Hepatic tumors in Saudi Arabia. A practical approach to diagnosis.
Kingston M; Ali MA; Lewall D
Cancer; 1985 Apr; 55(7):1579-85. PubMed ID: 2579717
[TBL] [Abstract][Full Text] [Related]
6. A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients.
Nicolini A; Carpi A; Di Marco G; Giuliani L; Giordani R; Palla S
Cancer; 1989 May; 63(10):2037-46. PubMed ID: 2702573
[TBL] [Abstract][Full Text] [Related]
7. Biliary carcinoembryonic antigen levels in diagnosis of occult hepatic metastases from colorectal carcinoma.
Waisberg J; Palma RT; Neto LC; Martins LC; Oliveira MS; Nagashima CA; Godoy AC; Goffi FS
World J Gastroenterol; 2003 Jul; 9(7):1589-93. PubMed ID: 12854170
[TBL] [Abstract][Full Text] [Related]
8. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of current diagnostic procedures for assessment of hepatic metastases in colorectal cancers.
Arnaud JP; Thibaud D; Leguillou A; Bergamaschi R; Adloff M
Eur J Surg Oncol; 1987 Aug; 13(4):355-8. PubMed ID: 2887457
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers.
Kutun S; Celik A; Hatiboglu C; Ulucanlar H; Cetin A
Surg Today; 2003; 33(8):590-4. PubMed ID: 12884096
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatic metastases from cancer of the breast.
Sugarbaker PH; Beard JO; Drum DE
Am J Surg; 1977 Apr; 133(4):531-5. PubMed ID: 848688
[TBL] [Abstract][Full Text] [Related]
14. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
15. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
[TBL] [Abstract][Full Text] [Related]
16. Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.
Molina R; Jo J; Zanón G; Filella X; Farrus B; Muñoz M; Latre ML; Pahisa J; Velasco M; Fernandez P; Estapé J; Ballesta AM
Br J Cancer; 1996 Oct; 74(7):1126-31. PubMed ID: 8855986
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases.
Munjal D; Chawla PL; Lokich JJ; Zamcheck N
Cancer; 1976 Apr; 37(4):1800-7. PubMed ID: 4219
[TBL] [Abstract][Full Text] [Related]
18. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
Wanebo JH; Stearns M; Schwartz MK
Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
[TBL] [Abstract][Full Text] [Related]
19. Screening for liver metastases from ovarian cancer with serum carcinoembryonic antigen and radionuclide hepatic scintiphotography.
Sonnendecker EW; de Souza JJ; Herman AA
Br J Obstet Gynaecol; 1984 Feb; 91(2):187-92. PubMed ID: 6696863
[TBL] [Abstract][Full Text] [Related]
20. The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer.
Nicolini A; Carpi A; Ferrari P; Anselmi L; Spinelli C; Conte M; Miccoli P
Br J Cancer; 2000 Dec; 83(11):1412-7. PubMed ID: 11076646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
